← News·Markets · OutlookMarkets

Ademi LLP opens fiduciary probe into NextCure's deal with Avere Therapeutics

Milwaukee law firm Ademi LLP has opened an investigation into NextCure (NASDAQ: NXTC), examining whether the biotech's recently announced transaction with Avere Therapeutics delivers a fair price to public shareholders.…

NM
NewsMV Markets Desk
3 min read
18 July 2026Markets desk
Share this dispatch
Categorymarkets

Filed via prnewswire.com

Keep reading

More from the markets desk